Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AIMD vs RENX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AIMD Wins Head-to-Head Institutional Verdict (3–1 across 6 Pillars · 8–2 Matrix Metrics)

AIMD Overall Winner 6-Pillar Tally: AIMD 3 – 1 RENX (2 Tie) Matrix Metrics: AIMD 8 – 2 RENX

As of Nov 20, 2026, Ainos, Inc. (AIMD) is the stronger overall head-to-head candidate over RENX (RENX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AIMD carries a Unified Composite Score of 23.4/100 (STRONG SELL) at $1.18 (13.9x Forward P/E, -101210.2% operating margin), whereas RENX carries 44.0/100 (HOLD) at $0.74 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While RENX currently prints a higher short-term Unified Composite Score (44.0/100 HOLD vs. AIMD 23.4/100 STRONG SELL), AIMD captures the overall institutional head-to-head verdict (8–2 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-101210.2% vs. N/A operating margin) and revenue trajectory (-96.7% vs. N/A YoY).
  • Technical & Structure Timing Caution: AIMD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 59.3); meanwhile RENX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AIMD vs RENX
AIMD NASDAQ Head-to-Head Winner
Ainos, Inc. Common Stock
Pharmaceutical Preparations
$1.18
+6.31% 1D
Market Cap $8.4M
TTM Revenue $13,600
Forward P/E 13.9x
Beta / 30D Vol 2.03β · 437% Vol
Unified Composite Score
23.4 / 100 STRONG SELL
Tech 50.0 Fund 31.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 59
RSI-14: 59.3 · SMA20: $0.84 · SMA50: $1.06
RENX US Equity
RENX
Institutional Equity
$0.74
-23.09% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -17.85β · 161% Vol
Unified Composite Score
44.0 / 100 HOLD
Tech 33.0 Fund 52.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.4%), weak momentum, RSI 32
RSI-14: 31.6 · SMA20: $1.05 · SMA50: $1.49

6-Pillar Scorecard Institutional Category Breakdown (AIMD 3 – 1 RENX)

Columns: Metric · AIMD · RENX
1. Valuation Multiples AIMD
Forward P/E 13.9x N/M
Trailing P/E 13.9x N/M
PEG Ratio 0.93x N/M
EV / Revenue N/M N/M
2. Growth & Scale AIMD
Revenue Growth (YoY) -96.7% N/A
Earnings Growth (YoY) +0.0% N/A
TTM Revenue (USD) $13,600 N/A
Market Cap $8.4M N/A
3. Profitability & Quality AIMD
Gross Margin 78.7% N/A
Operating Margin -101210.2% N/A
Net Profit Margin 0.0% N/A
Return on Equity (ROE) -196.3% N/A
4. Balance Sheet & Cash Flow RENX
Cash Generation (TTM) -$4.4M N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $11M Net Debt (2.43x D/E) N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Scientific & Technical Instruments Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AIMD (8) vs RENX (2)
Institutional Metric AIMD RENX Criterion Row Edge
Market Capitalization
Scale
$8.4M N/A Larger Scale AIMD
Trailing P/E Ratio
Valuation
13.9x N/M Lower Multiple AIMD
Forward P/E Ratio
Valuation
13.9x N/M Lower Multiple AIMD
Revenue Growth (YoY)
Growth
-96.7% N/A Higher Growth AIMD
Operating Margin (TTM)
Profitability
-101210.2% N/A Higher Margin AIMD
Net Profit Margin
Profitability
0.0% N/A Higher Margin AIMD
Return on Equity (ROE)
Capital Efficiency
-196.3% N/A Higher ROE AIMD
52-Week Range Position
Momentum
22% ($0–$4) 19% ($0–$3) Stronger Trend AIMD
Beta / 30D Volatility
Risk Regime
2.03β · 437% Vol -17.85β · 161% Vol Lower Realized Risk RENX
Unified Institutional Score
Composite Signal
23.4 / 100 (STRONG SELL) 44.0 / 100 (HOLD) Higher Composite RENX
Trailing 12M Revenue (USD)
Operating Scale
$13,600 N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
78.7% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.93x PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$4.4M ($11M Net Debt (2.43x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AIMD +88.0 pp
AIMD: +39.79% · RENX: -48.21%
3M Horizon AIMD +47.56 pp
AIMD: -15.11% · RENX: -62.67%
6M Horizon AIMD +29.67 pp
AIMD: -22.88% · RENX: -52.55%
1Y Horizon RENX +207.66 pp
AIMD: -44.08% · RENX: +163.58%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AIMD vs RENX. Trailing 12-month operating profitability (AIMD -101210.2% vs RENX N/A) and valuation multiples (AIMD 13.9x vs RENX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AIMD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$13,600
Gross Margin78.7%
Op. Margin-101210.2%
ROE / Fwd P/E-196.3% · 13.9x
RENX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AIMD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AIMD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
RENX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RENX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AIMD Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $8.4M market capitalization and -101210.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
RENX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AIMD vs RENX Key Questions & Quantitative Answers

As of Nov 20, 2026, Ainos, Inc. (AIMD) is the stronger overall head-to-head candidate over RENX (RENX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AIMD carries a Unified Composite Score of 23.4/100 (STRONG SELL) at $1.18 (13.9x Forward P/E, -101210.2% operating margin), whereas RENX carries 44.0/100 (HOLD) at $0.74 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While RENX currently prints a higher short-term Unified Composite Score (44.0/100 HOLD vs. AIMD 23.4/100 STRONG SELL), AIMD captures the overall institutional head-to-head verdict (8–2 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (-101210.2% vs. N/A operating margin) and revenue trajectory (-96.7% vs. N/A YoY). Technical & Structure Timing Caution: AIMD trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 59.3); meanwhile RENX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AIMD leads the Growth & Scale pillar: AIMD posts -96.7% YoY revenue growth and +0.0% YoY earnings growth on $13,600 TTM revenue (78.7% gross margin, -101210.2% operating margin), compared with RENX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, AIMD generates $13,600 in USD-normalized revenue versus N/A for RENX. In operating R&D and SG&A reinvestment, AIMD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for RENX.

AIMD screens cheaper on headline valuation multiples. AIMD trades at 13.9x Forward P/E, 13.9x Trailing P/E, 0.93x PEG, and N/M EV/Revenue (unreported FCF margin), whereas RENX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AIMD (-196.3% ROE) versus RENX (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, AIMD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.03β · 437% Vol realized risk). By comparison, RENX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-17.85β · 161% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.